Sector Chart Amplia Therapeutics Limited

Stocks

ATX

AU0000023822

Biotechnology & Medical Research

Market Closed - Australian S.E. 09:10:27 04/09/2026 +03			5-day change	1st Jan Change
0.1300 ^AUD	-3.70%		-13.33%	-13.33%

08-04	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly; Shares Rise 7%	MT
08-04	Amplia Therapeutics to Evaluate Combination Therapy for Non-Small Cell Lung Cancer in Collaboration With Eli Lilly	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
AMPLIA THERAPEUTICS LIMITED	49.86M	-	-	-	-	-
WUXI APPTEC CO., LTD.	69.02B
ARGENX SE	66.32B
INSMED INCORPORATED	27.66B					-
BIONTECH SE	25.84B					-
WUXI BIOLOGICS (CAYMAN) INC.	26.54B